Compounds > bicalutamide

bicalutamide and Lung Neoplasms

bicalutamide has been researched along with Lung Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Agbarya, A; Bar-Sela, G; Charas, T; Hijab, A; Stein, P; Taha, T1
Bossi, P; Civelli, E; Cortelazzi, B; Imbimbo, M; Licitra, L; Locati, LD; Perrone, F; Pilotti, S; Potepan, P; Quattrone, P; Rinaldi, G1
Duensing, S; Grüllich, C; Hadaschik, BA; Höfner, T; Hohenfellner, M; Jäger, D; Pahernik, S; Vallet, S1
Byrne, NM; McKenna, DJ; McKeown, SR; Ming, L; Nesbitt, H; Worthington, J1
Kirby, R1
Abe, H; Katsuoka, Y; Nishida, T; Segawa, N1

Other Studies

6 other study(ies) available for bicalutamide and Lung Neoplasms

ArticleYear
Anti-androgen for myoepithelial tumor: a potent therapy yet a potential misleader.
    Anti-cancer drugs, 2022, 01-01, Volume: 33, Issue:1

    Topics: Aged; Androgen Antagonists; Anilides; Humans; Lung Neoplasms; Male; Myoepithelioma; Neoplasm Metastasis; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Tosyl Compounds

2022
Activity of abiraterone in rechallenging two AR-expressing salivary gland adenocarcinomas, resistant to androgen-deprivation therapy.
    Cancer biology & therapy, 2014, Jun-01, Volume: 15, Issue:6

    Topics: Adenocarcinoma; Adult; Androgen Antagonists; Androstenes; Androstenols; Anilides; Antineoplastic Agents, Hormonal; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Receptors, Androgen; Salivary Gland Neoplasms; Tosyl Compounds; Treatment Outcome; Triptorelin Pamoate

2014
Docetaxel followed by abiraterone in metastatic castration-resistant prostate cancer: efficacy and predictive parameters in a large single center cohort.
    World journal of urology, 2015, Volume: 33, Issue:6

    Topics: Aged; Androgen Antagonists; Androstenes; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Buserelin; Cohort Studies; Disease-Free Survival; Docetaxel; Flutamide; Humans; Leuprolide; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Nitriles; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; Taxoids; Tosyl Compounds; Treatment Outcome; Triptorelin Pamoate

2015
Androgen deprivation in LNCaP prostate tumour xenografts induces vascular changes and hypoxic stress, resulting in promotion of epithelial-to-mesenchymal transition.
    British journal of cancer, 2016, Mar-15, Volume: 114, Issue:6

    Topics: Androgen Antagonists; Anilides; Animals; Cell Growth Processes; Cell Hypoxia; Cell Line, Tumor; Dose-Response Relationship, Drug; Epithelial-Mesenchymal Transition; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, SCID; Neovascularization, Pathologic; Nitriles; Oxygen; Prostatic Neoplasms; Tosyl Compounds; Xenograft Model Antitumor Assays

2016
Case study: management of advanced prostate cancer with soft tissue metastases.
    Prostate cancer and prostatic diseases, 2005, Volume: 8, Issue:3

    Topics: Adenocarcinoma; Anilides; Disease Progression; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Nitriles; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Quality of Life; Risk; Soft Tissue Neoplasms; Time Factors; Tomography, X-Ray Computed; Tosyl Compounds; Treatment Outcome

2005
[A case of prostatic cancer discovered from lung metastatic lesions].
    Hinyokika kiyo. Acta urologica Japonica, 2006, Volume: 52, Issue:2

    Topics: Adenocarcinoma; Aged; Anilides; Antineoplastic Agents, Hormonal; Drug Administration Schedule; Humans; Leuprolide; Lung Neoplasms; Male; Neoplasm Staging; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Tomography, X-Ray Computed; Tosyl Compounds

2006